This article has been corrected: In Figure 2, panels A and B contain accidental ‘placeholder’ images that contain partial duplications of panels E and G. The corrected figure 2, obtained using the original data, shown below. The authors declare that these corrections do not change the results or conclusions of this paper.
Figure 2. Transplantation results following in vitro redirection.
(A, B) H&E staining of mammary outgrowth following MEC transplantation. (C) H&E staining of mammary tumor that formed following transplantation of SkBr3-RFP cells. (D) Fluorescent image of C. (E) H&E staining of mammary outgrowth and mammary tumor following transplantation of HER2+ 1:1 fraction. (F) Fluorescent image of E. (G) H&E staining of HER2+ 1:50 fraction. (H) Fluorescent image of outlined area in G. (I) Transplantation results. (J) Survival curve of animals listed in I. Scale bars A, B, E, F, G = 200 μm, C, D, H = 400 μm.
Original article: Oncotarget. 2020; 11:2919–2929. 2919-2929. https://doi.org/10.18632/oncotarget.27679